News & Updates
Filter by Specialty:
Biweekly cabazitaxel plus G-CSF beneficial to certain older mCRPC patients
In the treatment of older patients with metastatic castration-resistant prostate cancer (mCRPC) who are considered unsuitable candidates for standard cabazitaxel (CBZ) regimens, treatment with CBZ at 16 mg/m2 (biweekly CBZ16) plus prophylactic granulocyte colony–stimulating factor (G-CSF) at each cycle helps reduce the risk of higher grade neutropenia and/or neutropenic complications while yielding similar clinical outcomes, according to the results of the phase III CABASTY trial.
Biweekly cabazitaxel plus G-CSF beneficial to certain older mCRPC patients
27 Nov 2023
Which factors predict pulmonary hypertension in ILD?
Multiple risk factors for pulmonary hypertension such as age, sex, and weight, among others, do not appear to influence the severity of interstitial lung disease (ILD), according to a recent study presented at APSR 2023.
Which factors predict pulmonary hypertension in ILD?
26 Nov 2023
Comprehensive approach needed for better asthma care
Simply developing evidence-based recommendations is not enough to improve asthma care. These recommendations should also be disseminated and implemented at national and local levels, then integrated into routine clinical practice to have a positive effect on patient outcomes, according to an expert.
Comprehensive approach needed for better asthma care
26 Nov 2023
Treatment choices influence rescue medication use in asthma
In patients with poor asthma control, switching from fluticasone propionate (FP) monotherapy to inhaled corticosteroid (ICS) plus a long-acting beta-agonist (LABA) combination therapy may help improve symptom control and reduce the use of reliever or rescue medications, according to a study.
Treatment choices influence rescue medication use in asthma
25 Nov 2023
Outpatient initiation of venetoclax safe, feasible in acute myeloid leukaemia
Initiation of venetoclax for acute myeloid leukaemia (AML) in the outpatient setting with a pharmacist-led interdisciplinary protocol is both feasible and safe, reports a study.